Mark H. Kuniholm

Mark H. Kuniholm, PhD, MS

I have long-standing interests in the epidemiology of viral hepatitis, HIV and other pathogens of global significance.

The World Within Reach
Mark H. Kuniholm, PhD, MS
Associate Professor

School of Public Health
Department: Epidemiology and Biostatistics

GEC 137



PhD, 2007, Epidemiology; Johns Hopkins Bloomberg School of Public Health
MS, 2002, Epidemiology; University of California, Davis
BA, 1996, Biology; Colorado College

Research Interests

Identification of host genetic factors that affect pathogenesis of viral infections and response to antiviral therapies; identification of mechanistic pathways through which viral infections perturb innate and adaptive immune responses and contribute to the development of non-infectious conditions (e.g., cardiovascular disease); implementation research, and identification of barriers to care for individuals at risk for or infected with viral hepatitis and/or HIV.

Additional Information

Frequently Taught Courses:

EPI 605 Infectious Disease Epidemiology (3)
EPI 610 AIDS Epidemiology (3)


  • Kuniholm MH, Jung M, Del Amo J, Talavera GA, Thyagarajan B, Hershow RC, Damas OM, Kaplan RC. Awareness of Hepatitis C Virus Seropositivity and Chronic Infection in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Journal of Immigrant and Minority Health. 2016. In Press
  • Kuniholm MH, O’Brien, TR, Prokunina-Olsson L, Augenbraun A, Plankey M, Karim R, Sarkar M, French AL, Pierce C, Strickler HD, Anastos K. Association of Hepatitis C Virus Infection with CD4/CD8 Ratio in HIV-Positive Women. JAIDS. 2016. 72(2): 162-70.
  • Kuniholm MH, Ong E, Hogema BM, Koppelman M, Anastos K, Peters MG, Seaberg EC, Chen Y, Nelson KE, Linnen JM. Acute and Chronic Hepatitis E Virus Infection in HIV-Infected United States Women. Hepatology. 2016. 63(3):712-20.
  • Jung M, Kuniholm MH, Ho GY, Cotler S, Strickler HD, Thyagarajan B, Youngblood M, Kaplan RC, Del Amo J. The distribution of Hepatitis B virus exposure and infection in a population-based sample of US Hispanic adults. Hepatology. 2016. 63(2):445-52.
  • Kuniholm MH, Leach, T, Lunievicz, J, Olivo N, Anastos K, Vazquez Y, Brennan-Ing M, Karpiak SE, Alao O, Nash D, Ernst J. Hepatitis C Direct Acting Antiviral Therapies in a New York City HIV/AIDS Special Needs Plan: Uptake and Barriers. AIDS Pat Care STDs. 2015. 29(12):643-5.
  • Kuniholm MH, Jung M, Everhart JE, Cotler S, Heiss G, McQuillan G, Kim RS, Strickler HD, Thyagarajan B, Youngblood M, Kaplan RC, Ho GYF. Prevalence of Hepatitis C Virus Infection in US Hispanic/Latino Adults: Results from the NHANES 2007–2010 and HCHS/SOL Studies. Journal of Infectious Diseases. 2014. 209(10):1585-90.
  • Kuniholm MH, Parrinello CM, Anastos K, Augenbraun M, Plankey M, Nowicki M, Peters Golub ET, Lurain N, Landay AL, Strickler HD, Kaplan RC. Hepatitis C Viremia is Associated with Cytomegalovirus IgG Antibody Levels in HIV-Infected Women. PLOS ONE. 2013. 8(4):e61973.
  • Kuniholm MH, Gao X, Xue X, Kovacs A, Marti D, Greenblatt RM, Cohen MH, Minkoff H, Gange S, Anastos K, Fazzari M, Young M, Strickler HD, Carrington M. Human Leukocyte Antigen (HLA) Genotype and Risk of HIV Disease Progression Before and After Initiation of Antiretroviral Therapy. Journal of Virology. 2011. 85(20):10826-33.
  • Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of Hepatitis E Virus in the United States: Results from NHANES III, 1988-1994. Journal of Infectious Diseases. 2009; 200(1):48-56.
  • Kuniholm MH, Wolfe ND, Huang CY, Mpoudi-Ngole E, Tamoufe U, Burke DS, Gubler DJ. Seroprevalence and Distribution of Flaviviridae, Togaviridae, and Bunyaviridae Infections in Rural Cameroonian Adults. American Journal of Tropical Medicine and Hygiene. 2006; 74 (6):1078-83.